Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 17th International Conference on Malignant Lymphoma (17-ICML) was held in Lugano, Switzerland, from June 13-17, 2023, and brought together leading experts as they discussed updates in basic and translational research, clinical studies, and innovation in the field of lymphoma.
View all videos

ICML 2023

The 17th International Conference on Malignant Lymphoma
13–17 June 2023 | Lugano, Switzerland
VJHemOnc avatar; VJHemOnc @VJHemOnc ·
9 Sep 1700569836688945474

It’s the final day of #SOHO2023 – we can’t believe it’s almost over!

We'd like to say a huge thank you to the organizing committee for having us onsite and to everyone who spoke with us this year!

Check out our interviews on http://VJHemOnc.com🎥

@SocietyofHemOnc

Image for the Tweet beginning: It’s the final day of Twitter feed image.
Reply on Twitter 1700569836688945474 Retweet on Twitter 1700569836688945474 0 Like on Twitter 1700569836688945474 0 View Tweet 1700569836688945474
Retweet on Twitter VJHemOnc Retweeted
SocietyofHemOnc avatar; Society of Hematologic Oncology (SOHO) @SocietyofHemOnc ·
9 Sep 1700539879455612993

Next questions in indolent #lymphoma according to ⁦⁦@LNastoupilMD⁩ #bispecifics? #Car-t therapies? #Btk inhibitors? Beyond chemo for front line? Things that occupy her mine ⁦@MDAndersonNews⁩ #soho2023 ⁦@donnashort⁩

Image for the Tweet beginning: Next questions in indolent #lymphoma Twitter feed image.
Reply on Twitter 1700539879455612993 Retweet on Twitter 1700539879455612993 2 Like on Twitter 1700539879455612993 9 View Tweet 1700539879455612993
Retweet on Twitter VJHemOnc Retweeted
SocietyofHemOnc avatar; Society of Hematologic Oncology (SOHO) @SocietyofHemOnc ·
9 Sep 1700545541581468099

Future directions in #mantlecell #lymphoma ⁦@AndreGoyMD⁩ #soho2023 new combinations! There is a sequential window. Induction and consolidation approaches are still evolving ⁦@HMHNewJersey⁩ ⁦@donnashort⁩

Image for the Tweet beginning: Future directions in #mantlecell #lymphoma Twitter feed image.
Reply on Twitter 1700545541581468099 Retweet on Twitter 1700545541581468099 4 Like on Twitter 1700545541581468099 7 View Tweet 1700545541581468099
VJHemOnc avatar; VJHemOnc @VJHemOnc ·
9 Sep 1700538309250888003

A fabulous catch up with @MDmasarova! Stay tuned for big #MPNsm updates!

Stay tuned 👉http://vjhemonc.com👈

@MDAndersonNews @SocietyofHemOnc #SOHO23 #SOHO2023 #MPNsm #MyeloproliferativeNeoplasms #HemOnc

Image for the Tweet beginning: A fabulous catch up with Twitter feed image.
Reply on Twitter 1700538309250888003 Retweet on Twitter 1700538309250888003 0 Like on Twitter 1700538309250888003 5 View Tweet 1700538309250888003
VJHemOnc avatar; VJHemOnc @VJHemOnc ·
9 Sep 1700537276751626679

Big updates from John Mascarenhas this morning at #SOHO2023!

Stay tuned 👉http://vjhemonc.com👈

@IcahnMountSinai @SocietyofHemOnc #SOHO23 #SOHO2023 #MPNsm #MyeloproliferativeNeoplasms #HemOnc

Image for the Tweet beginning: Big updates from John Mascarenhas Twitter feed image.
Reply on Twitter 1700537276751626679 Retweet on Twitter 1700537276751626679 0 Like on Twitter 1700537276751626679 0 View Tweet 1700537276751626679
Load More...

ICML 2023

The 17th International Conference on Malignant Lymphoma
13–17 June 2023 | Lugano, Switzerland
The 17th International Conference on Malignant Lymphoma (17-ICML) was held in Lugano, Switzerland, from June 13-17, 2023, and brought together leading experts as they discussed updates in basic and translational research, clinical studies, and innovation in the field of lymphoma.
View all videos
VJHemOnc avatar; VJHemOnc @VJHemOnc ·
9 Sep 1700569836688945474

It’s the final day of #SOHO2023 – we can’t believe it’s almost over!

We'd like to say a huge thank you to the organizing committee for having us onsite and to everyone who spoke with us this year!

Check out our interviews on http://VJHemOnc.com🎥

@SocietyofHemOnc

Image for the Tweet beginning: It’s the final day of Twitter feed image.
Reply on Twitter 1700569836688945474 Retweet on Twitter 1700569836688945474 0 Like on Twitter 1700569836688945474 0 View Tweet 1700569836688945474
Retweet on Twitter VJHemOnc Retweeted
SocietyofHemOnc avatar; Society of Hematologic Oncology (SOHO) @SocietyofHemOnc ·
9 Sep 1700539879455612993

Next questions in indolent #lymphoma according to ⁦⁦@LNastoupilMD⁩ #bispecifics? #Car-t therapies? #Btk inhibitors? Beyond chemo for front line? Things that occupy her mine ⁦@MDAndersonNews⁩ #soho2023 ⁦@donnashort⁩

Image for the Tweet beginning: Next questions in indolent #lymphoma Twitter feed image.
Reply on Twitter 1700539879455612993 Retweet on Twitter 1700539879455612993 2 Like on Twitter 1700539879455612993 9 View Tweet 1700539879455612993
Retweet on Twitter VJHemOnc Retweeted
SocietyofHemOnc avatar; Society of Hematologic Oncology (SOHO) @SocietyofHemOnc ·
9 Sep 1700545541581468099

Future directions in #mantlecell #lymphoma ⁦@AndreGoyMD⁩ #soho2023 new combinations! There is a sequential window. Induction and consolidation approaches are still evolving ⁦@HMHNewJersey⁩ ⁦@donnashort⁩

Image for the Tweet beginning: Future directions in #mantlecell #lymphoma Twitter feed image.
Reply on Twitter 1700545541581468099 Retweet on Twitter 1700545541581468099 4 Like on Twitter 1700545541581468099 7 View Tweet 1700545541581468099
VJHemOnc avatar; VJHemOnc @VJHemOnc ·
9 Sep 1700538309250888003

A fabulous catch up with @MDmasarova! Stay tuned for big #MPNsm updates!

Stay tuned 👉http://vjhemonc.com👈

@MDAndersonNews @SocietyofHemOnc #SOHO23 #SOHO2023 #MPNsm #MyeloproliferativeNeoplasms #HemOnc

Image for the Tweet beginning: A fabulous catch up with Twitter feed image.
Reply on Twitter 1700538309250888003 Retweet on Twitter 1700538309250888003 0 Like on Twitter 1700538309250888003 5 View Tweet 1700538309250888003
VJHemOnc avatar; VJHemOnc @VJHemOnc ·
9 Sep 1700537276751626679

Big updates from John Mascarenhas this morning at #SOHO2023!

Stay tuned 👉http://vjhemonc.com👈

@IcahnMountSinai @SocietyofHemOnc #SOHO23 #SOHO2023 #MPNsm #MyeloproliferativeNeoplasms #HemOnc

Image for the Tweet beginning: Big updates from John Mascarenhas Twitter feed image.
Reply on Twitter 1700537276751626679 Retweet on Twitter 1700537276751626679 0 Like on Twitter 1700537276751626679 0 View Tweet 1700537276751626679
Load More...

Latest videos

View all videos
1:09
Loncastuximab tesirine: long-term survival data from LOTIS-2 & insights into the LOTIS-7 trial
Juan Alderuccio • 15 Jun 2023
1:15
SWOG S1826: promising results with the combination of nivolumab-AVD in Hodgkin lymphoma
David Bond • 16 Jun 2023
1:34
PET-guided treatment: the new standard of care in Hodgkin lymphoma?
Peter Borchmann • 15 Jun 2023
1:52
Follicular lymphoma: the value of immunotherapies & other exciting areas of research
Mitch Smith • 15 Jun 2023

DLBCL

View all
1:09
Loncastuximab tesirine: long-term survival data from LOTIS-2 & insights into the LOTIS-7 trial
Juan Alderuccio • 15 Jun 2023
0:49
SUNMO: mosunetuzumab + polatuzumab vedotin vs R-GemOx in R/R aggressive NHL
Jason Westin • 16 Jun 2023

Follicular lymphoma

View all
1:52
Follicular lymphoma: the value of immunotherapies & other exciting areas of research
Mitch Smith • 15 Jun 2023
1:30
The role of tafasitamab in the lymphoma treatment landscape & promising results from clinical trials
Graham Collins • 16 Jun 2023

Immuno-oncology

View all
1:09
Loncastuximab tesirine: long-term survival data from LOTIS-2 & insights into the LOTIS-7 trial
Juan Alderuccio • 15 Jun 2023
1:15
SWOG S1826: promising results with the combination of nivolumab-AVD in Hodgkin lymphoma
David Bond • 16 Jun 2023
1:52
Follicular lymphoma: the value of immunotherapies & other exciting areas of research
Mitch Smith • 15 Jun 2023
0:49
SUNMO: mosunetuzumab + polatuzumab vedotin vs R-GemOx in R/R aggressive NHL
Jason Westin • 16 Jun 2023

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals